How to buy Eargo stock (Eargo)

Eargo is a medical devices business based in the US. Eargo shares (EAR) are listed on the NASDAQ and all prices are listed in US Dollars. Eargo employs 243 staff and has a trailing 12-month revenue of around $41.1 million.

Our top picks for where to buy Eargo stock

Buy Eargo stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Eargo stock price (NASDAQ: EAR)

Use our graph to track the performance of EAR stocks over time.

Eargo shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$2.55 - $2.87
50-day moving average more info button	$2.62
200-day moving average more info button	$3.13
Wall St. target price	$2.00
PE ratio more info button	0.1713
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$15.00

Is it a good time to buy Eargo stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Eargo stock undervalued or overvalued?

Valuing Eargo stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Eargo's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Eargo's P/E ratio

Eargo's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Eargo shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Eargo's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.

• Knowles Cor (KN.US): 37.71
• IntriCon Corporation (IIN.US): 0.00
• Nemaura Medical (NMRD.US): 0.00

Eargo financials

Revenue TTM	$41.1 million
Gross profit TTM	$14.3 million
Return on assets TTM	-60.08%
Return on equity TTM	-2457.08%
Profit margin	-263.14%
Book value	$2.17
Market Capitalization more info button	$53.4 million

TTM: trailing 12 months

Eargo share dividends

We're not expecting Eargo to pay a dividend over the next 12 months.

You may also wish to consider:

Have Eargo's shares ever split?

Eargo's shares were split on a 1:20 basis on 17 January 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Eargo shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Eargo shares which in turn could have impacted Eargo's share price.

Eargo share price volatility

Over the last 12 months, Eargo's shares have ranged in value from as little as $2.55 up to $2.87. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eargo's is 1.478. This would suggest that Eargo's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Eargo's beta into context you can compare it against those of similar companies.

• Knowles Cor (KN.US): 1.423
• IntriCon Corporation (IIN.US): 1.0054
• Nemaura Medical (NMRD.US): 0.083

Eargo overview

Eargo, Inc. , a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014.

Frequently asked questions

null
What percentage of Eargo is owned by insiders or institutions?
Currently 5.428% of Eargo shares are held by insiders and 6.386% by institutions. How many people work for Eargo?
Latest data suggests 243 work at Eargo. When does the fiscal year end for Eargo?
Eargo's fiscal year ends in December. Where is Eargo based?
Eargo's address is: 2665 North First Street, San Jose, CA, United States, 95134 What is Eargo's ISIN number?
Eargo's international securities identification number is: US2700871096